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The state of knowledge of health effects
from low-dose exposures to ionizing radia-
tion has recently been reviewed in extensive
reports by three prestigious national and
international commissions ofscientific and
medical experts with partially overlapping
membership, known by their acronyms
UNSCEAR (United Nations Scientific
Committee on the Effects of Atomic
Radiation)(1), BEIR V (Biological Effects
of Ionizing Radiation)(2), and ICRP
(International Commission on Radio-
logical Protection)(3). Publication of these
reports was followed by a number ofsum-
maries in scientific journals, authored by
recognized radiation experts, that purport
to present a scientific consensus of low-
dose effects in a more accessible format for
health professionals. A critical comparison
between various presentations of accepted
views, however, reveals inconsistencies
regarding "established" facts and unsettled
questions (4).
In 1990 the BEIR V Committee (com-
posed of 17 experts on radiation epidemiol-
ogy, bioeffects, and risk estimation) issued a
more than 400-page report (2) which serves
as awidely quoted and prestigious review of
low-dose radiation health effects. In the
body of this report, the committee
acknowledges some critical areas of uncer-
tainty and controversy, particularly with
regard to estimates of radiogenic risk per-
taining to anthropogenic increases in low-
dose exposures above unavoidable natural
background levels, both occupational and
environmental. Obviously, such estimates
are ofthe greatest importance to guidelines
for the protection of public health. Yet,
within the BEIR V report, we find incon-
sistencies between the committee's conclu-
sions, as stated on different pages. More-
over, few of these obviously unresolved
questions found their way into the most
widely quoted Executive Summary.
Subsequent authoritative overviews in sci-
entific journals have not only glossed over
some of these inconsistencies in the BEIR
V report, but they also present different
views ofwhat constitute "well established"
and "unproven" aspects of low-dose health
effects. We highlight some of these incon-
sistencies by quoting or paraphrasing state-
ments from the BEIR V report and com-
paring them with assertions on the same
topics from three subsequent journal
reviews, all citing BEIR V as a major
source. Editorial comments, reflecting on
the citations, have been placed in square
brackets. In our discussions, "low doses"
means the dose range well below 50 cGy.
We select five controversial issues in the
debate about protracted low-dose expo-
sures to illustrate our point.
BEIR V
Shape ofadose-effect curvefor cancer induc-
tion. In several places of its report (2), the
BEIR V Committee concurs with the large
team of scientists at the Radiation Effects
Research Foundation in Hiroshima, Japan,
which has collected and analyzed the Life
Span Study (LSS) ofA-bomb survivors for
decades: after a one-time (acute) exposure,
a linear, nonthreshold relation between
excess mortality from cancers, except
leukemia, and dose gives an excellent fit to
the 1950-1985 LSS data, if restricted to
doses below 200 cGy. However, BEIR V
"recognizes that its risk estimates become
more uncertain when applied to very low
doses," and the committee concedes rather
obliquely that "departures from a linear
model at low doses, however, could either
increase or decrease the risk per unit dose"
(2.-6).
Dose-rate effectivesness factor at low
doses. In its report, the BEIR V Committee
states: "For low-LET radiation [low linear
energy transfer, such as from [ and y radia-
tion], accumulation of the same [total]
dose over weeks or months, however, is
expected to reduce the lifetime risk appre-
ciably, possibly by a factor 2 or more" (2:
6). Such a downward correction for linear-
ly extrapolated risk values is called DREF
(dose rate effectiveness factor).
On the next page, however, we read:
While experiments with laboratory animals
indicate that the carcinogenic effectiveness per
Gy oflow-LET radiation is generally reduced
at low doses and low dose rates, epidemiologi-
cal data on the carcinogenic effects of low-
LET radiation are restricted largely to the
effects of exposures at high dose rates.
Continued research is needed, therefore, to
quantify the extent to which carcinogenic
effectiveness of low-LET radiation may be
reduced by fractionation or protraction of
exposure. (2: 7)
For decades, findings from animal
experiments at high doses have given sup-
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Address correspondence to RH. Nussbaum, 2393
SW Park Place, no. 301, Portland, OR 97205
USA.
Received 2 August 1993; accepted 9 May 1994.
Environmental Health Perspectives 656- _ _ _.- _ - 9 .99 9 99~ .9. 9 - -
subsequent section the report picks up the
same topic:
Since the risk models were derived primarily
from data on acute exposures. . . the applica-
tion ofthese models to continuous low dose-
rate exposures requires consideration of the
dose rate effectiveness factor (DREF).... For
the leukemia data, a linear extrapolation indi-
cates that the lifetime risks per unit bone
marrow dose may be halfas large for continu-
ous low dose rate as for instantaneous high
dose rate. For most other cancers in the LSS,
the quadratic contribution is nearly zero, and
the estimated DREFs are near unity.
Nevertheless, the committee judged that
some account should be taken of dose rate
effects and in Chapter 1 suggests a range of
DREFs that may be applicable. (2: 171)
Biological effectiveness ofX-rays versus y-
rays. Referring to work by a previous
authoritative radiation commission, the
International Commission on Radiation
Units and Measurement (ICRU)(5), BEIR
V states:
Most human exposures to low-LET ionizing
radiation are to X-rays, while the A-bomb
survivors received low-LET radiation in the
form ofhigh energy gamma rays. These are
reported to be only half as effective as ortho-
voltage X-rays. While that is not the conclu-
sion of this Committee, which did not con-
sider this question in detail, it could be
argued that since the risk estimates that are
presented in this report are derived chiefly (or
exclusively) from theJapanese experience they
should be doubled as they may be applied to
medical, industrial, or other X-ray exposures.
(2:218)
The physical basis for such a possible
effect is the roughly fourfold higher ioniza-
tion density in tissue by medical X-rays
than that byhigh-energy 7-rays (6).
Role offree radicals in tumorigenesis by
ionizing radiation. Regarding the role of
free radicals in tumorigenesis, the report
states: "To the extent that the effects of
radiation are mediated by free radicals,
which can also mediate the effects of pro-
moting agents, sequential exposures to
radiation may serve to promote tumorigen-
esis through mechanisms similar to those
ofchemical promoting agents" (2: 139).
The report gives no further considera-
tion to the question, whether radiogenic
free radical production, in particular, at
low doses and low dose rates could link
protracted low-level exposures to various
diseases or immune depression, known to
be promoted by these highly reactive
chemical species (7).
Radiation hormesis. On page 383 the
report states:
Although "beneficial" effects of radiation
have been alleged on the basis of reduced
mortality in high background areas in the
United States, analyses that include an adjust-
ment for altitude indicate no 'beneficial'
effects.... This apparently "beneficial" effect
of radiation may, in fact, be an example of
confounding... (2: 383)
The first of the three summaries in
Table 1 was published in ajournal for pub-
lic health professionals by members of the
BEIR V Committee (8). Hence its state-
ments conform largely with the BEIR V
report, except for some significant omis-
sions. The other two summaries (9,10) in
Table 1 show deviations, as well as omis-
sions, compared to the BEIR V report.
They have been directed to physicians and
radiologists in general. The usefulness of
reviewing unanswered questions after BEIR
V for the purpose ofidentifying new direc-
tions for investigations was recently recog-
nized byother researchers in the field (11).
This paper is predicated on the premise
that a special focus on unrefuted positive
associations of very low-dose exposures
with health effects that are inconsistent
with long-held notions will suggest
unorthodox hypotheses. Testing these
hypotheses will require investigations in
yet insufficiently explored areas that are
likely to reveal a greater-than-expected
complexity of interactions between low-
dose radiation exposures, other environ-
mental toxics, and disease.
Because of their dominance in shaping
prevalent notions about the effects ofradia-
tion, we briefly review the findings from the
A-bomb survivor study, with particular
emphasis on low-dose effects. In subsequent
sections we summarize some studies that are
pertinent to our above-stated premise.
Follow-up Study of A-bomb
Survivors
Evolution ofOfficial Low-Dose Radiation
Risk Estimates. Officially adopted radiation
risk estimates about health effects ofradia-
tion at low doses have been based primarily
on extrapolations from the continuing fol-
low-up study of about 90,000 inhabitants
of Hiroshima and Nagasaki who had sur-
vived the first 5 years after the physical and
social devastation caused by the atomic
bombs, followed by subsequent climatic
hardships. This cohort of 5-year survivors
[the Life Span Study (LSS) cohort] was
originally divided into eight subcohorts
with doses ranging from approximately 0
to over 400 cGy (rem). Until the mid-
1970s, cancer mortalities among survivors
with exposures below 100 cGy had not
shown statistically significant excesses
above Japanese national averages, in con-
trast to findings at higher exposures. To
respond to growing demands for occupa-
tional and general radiation protection
standards, national and international radia-
tion regulatory commissions had to resort
to models for downward extrapolation to
reasonable levels of occupational exposure
from the well-established high-dose obser-
vations. Those models were also influenced
by data from limited follow-up studies of
patients who had received high doses of
radiation for therapeutic purposes. By
implicitly postulating the existence of a
universally valid dose-effect relation and
by generalizing from high-dose experi-
ments on much shorter-lived rodents to
human response at much lower doses, the
ICRP (12) , UNSCEAR (13), and BEIR
III (14) reports in the late 1970s all con-
cluded either explicitly or implicitly that
linear, no-threshold extrapolation from
high-dose A-bomb survivor mortalities
would, in fact, overestimate low-dose radi-
ogenic risks. For fractionated low-dose
exposures (thus for most occupational and
environmental exposures), the radiation
committees recommended that linearly
extrapolated risk values should subsequent-
ly be corrected (divided) by dose-rate effec-
tiveness factors (DREFs) ofat least a factor
2, with the greatest risk reduction to be
applied to the lowest doses and/or dose
rates.
However, microdosimetric analyses
have shown that at decreasing doses, the
concept of dose rate loses its meaning
entirely because of the discrete nature of
the radiation-cell interaction: the smallest
possible effect must be caused by a single
cell traversal (15,16).
More recently, evaluations of cancer
risk from ionizing radiation have under-
gone significant upward revisions com-
pared to those published about a decade
earlier (1-3). Those revisions were necessi-
tated primarily by 1) considerable differen-
tial increases in cancer deaths among the
low-dose subcohorts of the A-bomb sur-
vivors during the follow-up period extend-
ed to 1985 (showing longer than expected
latencies) and 2) far-reaching revisions of
the individual dose estimates for the LSS
survivors (DS86 dosimetry).
For the nonleukemia A-bomb data,
Radiation Effects Research Foundation
(RERF) analysts found that a DREF value
much above one for acute low-dose expo-
sures is not consistent with the updated
data (17-19). Yet, disregarding the evi-
dence from the low-dose range of the A-
bomb survivor study, the above microdosi-
metric analyses, and epidemiological find-
ings from protracted, low-dose occupation-
al exposures, the summary conclusions by
UNSCEAR (1), BEIR V (2), and ICRP
(3) retained their previous recommenda-
tions to reduce estimates of radiogenic
risks, based on a linear dose-effect model,
for protracted low-dose exposures by
DREF corrections of at least a factor of
two.
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Table 1. Summaries after BEIR Va
Upton etal. (8) Hendee (9) Little (10)
Shape of dose-effect curvefor cancer induction
The nonthreshold dose-incidence hypothesis, first
supported bythe association between childhood
leukemia and prenatal diagnostic X-irradiation at
doses comparable to natural background, has
been extended to other malignancies, as well asto
genetically significant mutations. Data on terato-
genic effects (e.g., small brain size or severe men-
tal retardation) are also compatible with a non-
threshold linear dose-effect curve.
Dose-rate effectiveness (DREF) factorat lowdoses
Inthe absence of adequate human data on the
carcinogenicity of protracted low-LET irradiation,
the BEIR V Committee was unable to specifythe
extentto which their projections may overestimate
the risks of a dose of radiation that is accumulated
over long periods oftime.
Biological effectiveness ofX-rays versusy-rays
[Not mentioned.]




Although several studies have found thatthe rates
of cancer and other diseases vary inversely with
natural background radiation levels, which some
investigators have interpreted as evidence of ben-
eficial ("hormetic") effects of low-level irradiation;
the relationship does not persist afterthe effects
ofaltitude and other confounding variables have
been adequately controlled.
aEditorial comments are in brackets.
A-bomb survivor study as universal stan-
dard. The interpretations of A-bomb sur-
vivors' cancer mortality or incidence statis-
tics by scientists at RERF in Hiroshima and
other official commissions have become the
authoritative standard to which all findings
from epidemiological studies on other
exposed populations, such as nuclear work-
ers, have been compared. In particular, stud-
ies that found substantially higher radiogenic
risks at low doses and low dose-rates than
those officially adopted (20) have been
labeled "renegade" by some recognized radi-
ation experts and have been imputed to be
in error by others (21-23). Rather than
questioning the comparability of incongru-
ent studies, some epidemiologists invoke
The linear model furnishesthe most conservative
(i.e., highest) risk estimates for exposuresto low
doses of radiation, even though evidence estab-
lishing the linear model asthe correct relationship
is still relatively inconclusive.
Suggests that a DREF of 2.25 (from a 1980 BEIR
report) should be applied to the BEIR V risks. [No
specific justification is given, otherthan that it
would reduce risks closerto earlier estimates.]
[X-ray exposures of most medical workers far
below protection guidelines are discussed, but
there is no mention of a possibly higher biological
effectiveness ofX-rays compared toy-rays on
which the guidelines are based.]
[Notmentioned.]
[Notmentioned.]
bias of unknown origin in the occupational
data in order to set aside their own findings
if they differ from those derived from LSS
statistics (24). Scant attention has been given
to evidence in the RERF data that these dis-
crepancies might reflect unrecognized intrin-
sic incommensurabilities in health profiles
(such as lasting selection effects after the ini-
tial disaster in Hiroshima and Nagasaki,
combined for some survivors with perma-
nent immune depression) and age distribu-
tions between the LSS cohort and a worker
population-quite apart from the vastly dif-
ferent characteristics of irradiation (25,26).
Adopting the LSS findings as a universal
standard also implies the untested hypothesis
that a single dose-effect relationship can
Induction of mutations in human cells is a non-
threshold linearfunction of dose, independent of
dose rate. The dose-response for induction of
breast cancer is linear withoutthreshold. While
there are several epidemiological studies that
have purported to show carcinogenic or leuke-
mogenic effects of irradiation in the dose range
below 10 cGy, there are no theoretical reasons,
nor arethere supporting animal data , or low-dose
A-bomb survivor data inthe range 1-9 cGy sug-
gesting thatthere should be a convex upward
dose relation,thatwould be required to observe a
rapidly rising cancer incidence atvery low doses,
close to natural background.
The dose-rate effectfor induction of specific gene
mutations in human cells may be significantly less
than that observed in rodent cells. Nevertheless,
when the experimental data are considered along
with limited epidemiologic data, a DREF of 2 has
been recommended for chronic exposures.
However, little or no decrease in risk was
observed for induction of breast cancer, when the
dose was received in a protracted manner, as
opposed to a single brief exposure.
[Notmentioned.]
Ionization results in the production offree radicals
that are extremely reactive and may lead to per-
manent damage of affected molecules.
A lack of correlation between cancer incidence
and background radiation was observed in differ-
entstudies. Low-dose epidemiologic studies in
populations of limited size must be carefully con-
trolled, and are often prone to bias by confounding
factors.
describe all conditions ofexposure (23).
Evaluation ofincremental excess cancer
riskfrom mortalities among the lowest dose
subcohorts. Linear extrapolation models used
by BEIR V and RERF to predict low-dose
risk values can be checked by a straightfor-
ward analysis of mortality data, limited to
the lowest dose subcohorts. The methods
used in all official analyses ofA-bomb mor-
tality data have weighted the resulting risk
values toward those observed in the medi-
um- to high-dose range (22). Recently, two
groups ofresearchers published independent
analyses that were restricted to cancer mor-
talities among the A-bomb survivors who
had been exposed to less than 50 or 100 cGy
(16,28,29). These low-dose subcohorts
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include about 80% of the entire LSS
cohort. Using the 1950-1985 follow-up
data (30) and combining new DS86 subco-
horts from both cities, these authors have
shown statistically significant (p< 0.01)
excess mortalities (for cancers except
leukemia) for the combined 6-19 cGy sub-
cohort (mean colon dose 10.9 cGy) com-
pared to the combined 0-5 cGy subcohort
(mean colon dose 0.7 cGy) (Fig. 1). The
0-5 cGy dose group was chosen for com-
parison, rather than RERF's zero dose
group, since the combined sub-cohort
includes survivors, nominally unexposed to
the radiation flash from the explosions, as
well as an unknown fraction who at that
distance from the epicenter were affected
by fallout exposures (31). This additional
dose is not reflected in DS86 estimates of
individual doses. Other uncertainties have
arisen recently in regard to the contribu-
tions ofneutrons to individual doses ofsur-
vivors, especially affecting the low-dose
subcohorts who were located at large dis-
tances from the explosions (32,33). For the
lowest dose DS86 subcohorts, we can thus
expect that upward corrections in mean
doses will have to be made, with the great-
est correction to the lowest mean doses,
decreasing rapidly with increasing DS86
mean dose. A graphical display of cancer
mortality versus mean dose elucidates
more directly the relevant dose-response
association than the usual display ofrelative
riskversus dose (Fig. 1).
The distribution ofsurvivors according
to sex and age at exposure does not vary by
more than a few percent across the relevant
low-dose subcohorts (29). Consequently,
for the limited purpose of inspecting the
gross features of the dose-response rela-
tion, aggregate mortalities were analyzed,
introducing only negligible systematic
errors. Weighted linear regression analysis
over the dose ranges listed in Table 2 and
displayed in Figure 1 yields a higher slope
for mortality versus dose (or incremental
risk per unit dose) for the dose range 0-19
cGy than for the dose range 6-99 cGy.
While only weakly statistically significant,
the 1950-1985 survivor mortality data for
the low-dose range suggest that the incre-
mental excess cancer risk per cGy for single
exposures may be greater below 20 cGy
than in the medium dose range (20-100
cGy), for which our estimate ofexcess life-
time risk (9± 1)x104 p-cGy (Fig. 1; Table
2) is consistent with the value of about
12x104 p-cGy published by RERF ana-
lysts (30) or the value ofabout 7 104 p-
cGy from BEIR V (2) . To check our con-
jecture and possible bias from using aggre-
gate mortalities, one ofRERF's chiefstatis-
ticians applied a more extensive model for
fitting excess relative risk that includes
stratification for city, sex, age at exposure,
and follow-up period. For the mortality
data below 100 cGy, he found improve-
ment in the fit for excess relative risk, R,
proportional to the square root of dose
(convex curve) compared to a linear dose
dependence (Pierce DA, personal commu-
nication, 1991). Unfortunately, updated
mortality data for 1950-1990 have yet to
be published by RERF. Nonuniform
upward corrections to subcohort mean
doses due to unaccounted-for fallout or
neutron doses might well augment the
convex shape ofthe dose-effect relation. In
this context, it is noteworthy that RERF
analysts, studying the issue of a hypothe-
sized threshold and the shape of the
dose-response curve for leukemia (acute
lymphocytic leukemia or ALL and chronic
myeloid leukemia or CML) among the
LSS cohort at low doses, found a better fit
of the data to a nonthreshold convex
dose-effect relation (logarithmic with
dose) than to a linear one with a hypothe-
sized 5 cGy threshold (34).
Summary oflow-dose effects. Findings
from the A-bomb survivor follow-up stud-
ies (DS86, 1950-1985 follow-up) that
contradict the validity ofapplying a DREF
to low-dose exposures are as follows:
1) Both the A-bomb survivor cancer
mortality (1950-1985) and incidence data
(1950-1987) fail to suggest the existence
of a threshold for cancer induction down
to verylowdoses (19,35,36).
2) Doses less than 5 cGy and probably
as low as 1.6 cGy have been associated
with excess cases of leukemia (ALL and
CML) among A-bomb survivors (34,3X).
Table 2. Radiogenic cancer riskfor all cancers except leukemia and projected lifetime excess risks per
104 person-cGy(1950-1985)a
Subcohort Dose range Dose groups used Excess risk Estimated lifetime risk
dosimetry (cGy) inanalysis per 104p-cGy per 104p-cGy
Colon dose 0-49 0,-5,-9,-19,-49 5.0 ± 1.5 18.1 ± 4.9
0-19 0-5,6-19 9.1 ± 1.4 33 ± 5
6-99 6-19,-49,-99 2.8 ± 0.3 9.3 ± 1.1
8Table adopted from Nussbaum and Kohnlein (28,29).
bDose ranges in adjacent cSv intervals: -5 = 1-5; -9 =6-9; -19 =10-19, etc., exceptforthe dose groups 0
and -5 combined, indicated by0-5.
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Figure 1. Life Span Study mortality, 1950-1985,
from all cancers except leukemia. Cumulative
mortality per104survivors forthe lowest six colon
dose subcohorts (DS86) 0, 1-5, 6-9, 10-19, 20-49,
50-99 cGy (triangles) and for the two combined
0-5 (mean dose 0.7) and 6-19 (mean dose 10.9)
cGy subcohorts (squares) versus mean colon
dose (cGy). Standard error bars are shown. The
increase in mortalities between the 0-5 and 6-19
cGy subcohorts is statistically significant (p <
0.01). The solid line is an error-weighted linear fit
to the five data points below 40 cGy mean dose
(see Table 2). The two dashed lines are weighted
linear fits to the two data points for the combined
0-5 and 6-19 cGy dose groups (see Table 2) and
the three data points for the dose groups 6-19,
20-49, and 50-99 cGy with mean doses above 10
cGy (see Table 2), respectively. The slopes of the
three lines correspond to the three values of
excess risk per 10 person-cGy listed in Table 2.
[Data from Shimizu et al. (30)].
Carter (34) found a better fit ofthe data to
a nonthreshold upward convex dose-effect
relation (logarithmic with dose) than to a
linear one with a hypothesized 5 cGy
threshold (p=0.056).
3) Doses in the range from less than
one to a few cGy have been associated with
brain damage in prenatally exposed chil-
dren ofA-bomb survivors (38).
4) Mortality for solid cancers in the
6-19 cGy dose group (mean colon dose
10.9 cGy) is significantly higher (p<0.01)
than it is in the 0-5 cGy dose group (mean
colon dose 0.7 cGy), and there is evidence




nuclear worker studies. So far, practically all
epidemiological studies of nuclear worker
populations in the industrialized world
have been funded by government agencies.
A panel of 12 independent physicians and
epidemiologists, in a critical review of 124
governmental studies (39), concluded in
1992 that 1) "The DOE's (and its prede-
cessor agencies') epidemiology program is
seriously flawed. . .NO (391 61); 2) "There
appear to be major inaccuracies and serious
questions as to consistency and reliability
in the measurements ofthe radiation expo-
sures." (39c s 61); 3) "The nearly exclusive
focus on mortality studies. . . eliminates
from consideration virtually all cancers
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which may be related to radiation exposure
but which will not or have not yet caused
death, and thus severely limits our knowl-
edge of the health consequences of low-
level ionizing radiation exposure. . ." (39.
62); and 4) ". . the problems and flaws
evident in many investigations are precisely
those which tend to produce false negative
results" (39. 62).
A large number ofthe mortality studies
under review found no statistically signifi-
cant association between cancer induction
and low-dose radiation exposures. Most of
them extended over limited follow-up peri-
ods, too short to observe long latencies.
Also, when workers' mortalities are being
compared to national rates, the findings
are biased toward lower risk for all causes
ofdeath among radiation workers (healthy
worker effect).
Nevertheless, in a few of the reviewed
studies and in some that have been pub-
lished more recently, significant increases
in specific types of cancer were found; for
example, prostatic cancer (40,41), multiple
myeloma (24,42,44,45), lymphatic and
hemapoetic neoplasms and bladder cancer
(42), leukemia (43), and lung cancer
(46,47). These positive findings have
either been dismissed as due to unknown
causes or chance by the authors, or they
have been ignored in revisions ofradiation
protection standards (48).
However, there is no reasonable justifi-
cation for ignoring findings of positive
associations of radiogenic risk with expo-
sure on the basis of their smaller number
or because ofdisagreeing with inconclusive
or negative findings unless specific substan-
tial errors in the analysis can be shown.
Mutually inconsistent epidemiological
findings are likely indicators of essential
differences in sensitivity to detecting small
dose-related excess mortalities at low expo-
sures which depend critically on the choice
of case and control populations, on the
dependability of dose records over long
periods oftime, and on adequate statistical
controls for a variety of selection effects
associated with mortality rates(49).
Some nuclear worker studies over
extensive follow-up periods that included
statistical controls for external and internal
healthy worker selection effects, as well as
for several other confounding factors are
reviewed below.
Cancer mortality among Hanford work-
ers. The U.S. Atomic Energy Commission
(AEC) in 1964 contracted T.F. Mancuso
to study the lifetime health and mortality
experiences oftens ofthousands ofworkers
at the nuclear weapons production installa-
tions at Hanford, Washington; Oak Ridge,
Tennessee; and Los Alamos, New Mexico.
After a sufficiently long follow-up period,
the analysis by Mancuso et al. (50) for
1944-1977 deaths identified a small excess
of certain types of cancer among about
28,000 Hanford workers with cumulative
radiation exposures well below the maxi-
mum permissible dose. For another group
of cancers, they found a slightly negative
association with dose, an effect that
remained unexplained at the time. The
authors concluded that 1) low-dose, low
dose-rate radiogenic cancer risks appear to
be 10-20 times greater than those extrapo-
lated from the A-bomb survivor study, 2)
workers within the nuclear industry are an
the whole considerably healthier than the
general population, and within the work-
force, those who perform the riskier (and
higher paid) jobs are healthier than the
average worker (external and internal
healthy worker effect), 3) a supralinear
(convex) dose-response relation improved
the fit to their data in the lowest dose
range, 4) the most probable cancer latency
period was about 25 years, sometimes
extending to 40 or more years (50-53).
Those conclusions have been rejected by a
majority ofradiation scientists, who prefer
a Department ofEnergy (DOE)-sponsored
nuclear worker study, using a more con-
ventional method of analysis, different
methods of data stratification, and differ-
ent statistical controls for healthy worker
effects which found no statistically signifi-
cant association between recorded worker
doses and cancer mortality, except for mul-
tiple myeloma (44).
After years of an unresolved dispute
between rival analyses (54), a court settle-
ment granted Kneale and Stewart access to
the updated mortality data held by the
DOE. The Birmingham team reanalyzed
Hanford worker mortalities from 1944 to
1986, revising their original methodology
to a modified case-control study, an adap-
tation from the model used by the BEIR V
committee (2) for analysis of the A-bomb
survivor statistics. This model includes 10
"essential controlling factors" (confound-
ing factors that can obscure the association
between exposure and cancer) and three
"modulating factors" (factors that can alter
the dose-effect relation). Age at exposure
was included among both categories to
allow for change in sensitivity to cancer
induction with exposure age. The other
two modulating factors were exposure year
(to allow for variability in standards for
dose recording with changing technology
and management techniques) (55,56) and
interval between exposure and death or fol-
low-up. Kneale and Stewart (57) recon-
firmed their earlier finding ofa statistically
significant radiogenic risk for the work-
force as a whole for average occupational
doses considerably below the regulatory
limits. About 3% of all cancers were con-
sidered to be associated with recorded
occupational doses. In contrast to their
previous results and to those ofother occu-
pational studies, the authors found a
strongly increasing sensitivity for cancer
induction for exposures after age 55. Also,
the convex deviation from linearity of the
dose-effect relation in the occupational
dose range found previously (52) was no
longer statistically significant in the 1993
reanalysis (57). Uncertainties in dosimetry
might account in part for this change.
In a parallel analysis of essentially the
same mortality data, using a more conven-
tional methodology and a smaller number
of controlling and modifying factors,
Gilbert et al. (45) found a weak negative
association of radiogenic risk with increas-
ing occupational dose, except for multiple
myeloma. This result is qualitatively simi-
lar to the earlier finding by Kneale et al.
(52) ofa negative association with dose for
a group ofcancers in tissues, deemed to be
less radiosensitive at the time. However,
with the 1993 refinement of controls for
selection effects within the workforce and a
year-by-year recording of accumulated
occupational doses to allow for age-related
radiosensitivity, the association turned sig-
nificantly positive for all cancers (57).
Subsequently, a team ofDOE scientists
published a combined mortality study
among workers at three nuclear sites,
including Hanford. Gilbert et al. (24)
found positive associations with dose for
12 types of cancer: those for cancer of the
esophagus and the larynx, as well as for
Hodgkin's disease were statistically signifi-
cant. This study also corroborates the con-
clusion by Kneale and Stewart (57) of a
strong increase ofsensitivity for radiogenic
cancers with age. The bibliography (24)
suggests, however, that the DOE team may
have been unaware ofthis publication. The
significant radiogenic cancer risk at low
occupational dose levels, as well as the
strong effect of exposure age on risk, are
inconsistent with the interpretations ofthe
follow-up studies of acutely exposed A-
bomb survivors (2). Consequently, Gilbert
et al. (24) discount their significant posi-
tive associations, as well as the age effect,
ascribing them to unknown sources ofbias
or chance fluctuations.
Cancer mortality among Oak Ridge
workers. Frome and co-workers (58)
reported the first phase ofa comprehensive
study of the mortality of all white, male
workers employed at federal nuclear plants
in Oak Ridge, Tennessee during theWorld
War II era (1943-1947). After 30 years of
follow-up, the standardized mortality ratio
(SMR), a ratio of observed mortality over
the mortality among the U.S. population,
for all causes was 1.11, and there was a
significant upward trend of 0.74% per
year. The excess mortality was primarily
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due to lung cancer and diseases ofthe res-
piratory system.
Wing and co-workers (20,23) studied
more than 8000 Oak Ridge workers
(1943-1984) with accumulated occupa-
tional doses under 50 cSv for all but 0.2%
ofthe workers (mean dose 1.73 cSv, medi-
an 0.14 cSv). For about 25% ofthe cohort,
no measurable exposure was recorded,
while about 68% had records ofaccumulat-
ed doses below 5 cSv over their entire peri-
od ofemployment. As in Hanford, the Oak
Ridge research team found for the entire
cohort a strong external healthy worker
effect (SMR 0.74 for all causes and SMR
0.79 for all cancers). A subcohort ofwork-
ers who had at some time been monitored
for possible internal contaminations
showed a higher SMR value for leukemia
than the workforce as awhole.
The main conclusions from this study
are 1) there is an excess of leukemias
among the workforce, compared to the
general population (SMR 1.63), and 2) the
incremental relative risk for all cancers is
about 5% per cSv. This value is about 25
times greater than the risk estimate in
BEIR V (2) for low-dose exposures iftheir
recommended DREF of 2 for low dose-
rates is applied.
Two earlier studies in which the same
group of workers was followed through
1977 found no association between radia-
tion dose and cancer mortality (59,60).
Apart from having incorporated 7 more
years of follow-up, the Wing et al. (20)
study considered the effects ofvarious con-
trolling factors in greater detail.
Some negative reactions to the the Oak
Ridge worker study were reminiscent of
those to the first Hanford worker study
(50); however, Wing et al.'s findings stand
without asubstantive refutation.
Cancer mortality among British nuclear
workers. Beral et al. (61) followed a cohort
of about 22,000 workers employed by the
Atomic Weapons Establishment (1951-
1982) for an average of 18.6 years. They
found a significant healthy worker effect
(SMR 0.77 for all causes, 0.82 for all can-
cers), comparable to the U.S. findings.
With a lag time (latency) of at least 10
years, and for the most part among the
subcohort monitored also for internally
deposited radionuclides, a statistically sig-
nificant incremental risk (p< 0.001) of
7.6% per cGy was found, comparable to
the Oak Ridge results (20).
There are other mortality studies of
workers in British nuclear establishments
(41,42) that involved a larger number of
employees. Kendall et al. (62) pooled
workers from a number ofdifferent instal-
nations. Compared to the studies discussed
previously and the Beral et al. (61) study,
the pooled data showed a smaller or a sta-
tistically insignificant association ofcancers
with radiation. However, unless closely
similar in hiring criteria, standards for dose
recording, and exposure circumstances,
pooling of worker data from different
nuclear establishments can be expected to
reduce sensitivity of a low-dose epidemio-
logical study by diluting or masking small
but real correlations (63).
Leukemia mortality amongnuclear work-
ers. By pooling leukemia mortality data
from seven studies ofnuclearworkers in the
United States and Great Britain, Wilkinson
et al. (43) provided evidence of a modest
excess of leukemia from exposure to low
doses ofionizing radiation at low dose rates.
An adjusted relative riskof1.8 was observed
when individuals with 1-5 cSv exposure
were compared with those who had cumu-
lative occupational doses ofless than 1 cGy.
The combined data indicate a small elevat-
ed risk of leukemia for protracted doses of
ionizing radiation under 5 cSv. As men-
tioned above, the pooling of data with
nonuniform dosimetry and record keeping
procedures could well underestimate the
strength ofassociation found.
Mutational effects among radiotherapy
technicians. Messing and co-workers (64)
investigated whether mutant frequency in
peripheral T-lymphocytes of radiotherapy
technicians exposed on the average to 0.3
cGy per month of cobalt-60 y-radiation
can be associated with recently absorbed
dose. The study cohort consisted of 13
exposed technicians wearing dosimeters.
The matched controls were 12 physiother-
apy technicians working in the same hospi-
tal with no radiation exposure. The analy-
sis revealed that the mutation frequency is
linearly correlated with dose in the range
from 0-0.7 cGy. In radiotherapy patients
(treated for breast cancer), Messing et al.
observed after much higher doses (4 Gy)
mutation frequencies of only 1% of those
at the very low doses and dose rates. This
suggests that at higher doses multiple dam-
age and cell killing become prominent,
reducing the mutation yield.
Cancers amongcommercialairlinepilots.
Airline pilots are subject to cosmic radia-
tion, accumulating yearly doses up to
about 1 cGy, or the equivalent ofthree to
four times natural background for an aver-
age U.S. citizen (6-5). A cancer mortality
and incidence study among about 900
Canadian male pilots showed significant
excess rates for several cancers, including
Hodgkin's disease and nonmelanoma skin
cancer (66). By using a standardized mor-
tality ratio (SMR) analysis with the popu-
lation of British Columbia as the control
group, the positive findings represent
underestimates of excess incidence and
mortality rates because the reported
healthy worker effect (SMR 0.80 for all
causes of death) was not taken into
account. Individual dose estimates were
not included in the analysis; thus the find-
ings suggest, but do not firmly establish, an
association with exposure to low doses of
ionizing radiation, possibly in synergism
with exposures to a range of electromag-
netic frequencies and, for rectal cancer,
with a high-fat diet. High altitude expo-
sure and/or aviator status also correlate sig-
nificantly with cancerous conditions ofthe
skin, testicles, bladder, and thyroid in a
study of U.S. pilots (67). A study ofchro-
mosome aberrations induced in lympho-
cytes of pilots and stewardesses also con-
firms effects ofvery low-dose exposures in
this occupation (68).
Given the large number of pilots and
the readily available data on flight times,
elevations and monitored intensities ofcos-
mic radiation, this group presents a unique
opportunity to extend epidemiological
studies at low doses to these populations
worldwide.
Possible genetic effects oflow-dose expo-
sures. Gardner and co-workers (69,70) con-
ducted a case-control study of leukemia
and lymphoma among young people near
the Sellafield nuclear plant in West
Cumbria, Great Britain. A total of52 cases
of leukemia, 22 non-Hodgkin's lym-
phoma, and 23 cases ofHodgkin's disease,
occurring in people under age 25, born in
the area and diagnosed there from 1950 to
1985, were analyzed. A total of 1001
matched controls were included in the epi-
demiological study. Hodgkin's disease
cases showed no significant correlation
with the various factors under investiga-
tion. Gardner and his associates examined
several possible environmental pathways
for exposures to internal radioisotopes,
such as from playing on contaminated
beaches or eating contaminated seafood or
vegetables, or living in the proximity ofthe
Sellafield plant. Prenatal X-rays or viral
infections during pregnancy were also con-
sidered as factors in explaining the excess
leukemia cases. A high correlation of
leukemia cases was found, however, with
doses received by fathers working at
Sellafield before conception ofthe child. A
relative risk of about 7 was found if the
absorbed dose in the 6 months before con-
ception was more than 1 cSv. A similar rel-
ative risk (6.24) was observed if the total
accumulated exposure ofthe father was 10
cSv or more before conception. The fact
that ionizing radiation may be leuke-
mogenic to the offspring has important
potential implications for the protection of
radiation workers and their children, as
well as for radiation biology. It is for this
reason that the work by Gardner et al. has
received so much attention and continues
to stimulate vigorous debate (71,7Z).
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Leukemia clusters have also been found
near other British nuclear plants, several
supporting the findings of increased risk
for leukemia in young people, some cor-
roborating the genetic effects suggested by
Gardner et al., others inconclusive on this
score (73,74) A study of leukemia and
non-Hodgkin's lymphoma cases near
Seascale suggests the contribution ofother
causes to the excess because only part of
these cases could be accounted for by pre-
conceptual paternal exposure (75). Other
British studies found negative or ambigu-
ous results (76-79). The indications for
genetic effects from preconceptual parental
exposures are in part consistent with earlier
findings of elevated risks for several dis-
eases for children whose parents had been
exposed to diagnostic X-rays.
While some types of birth defects
showed significant association with parental
employment at Hanford but not with
monitored parental preconception doses,
other defects showed a significant associa-
tion with parental accumulated occupation-
al exposures. Taken together, the data were
in part contradictory, and the authors inter-
preted them as false positives (80).
An important extension and support for
the findings by Gardner et al. (70) was pro-
vided by the large database of the Oxford
Survey of Childhood Cancers. It showed
that elevated risk for genetically transmitted
childhood cancers was associated with
potential paternal exposure to internal
sources of radiation but not significantly
with recorded external exposures (81). In
the Gardner study, only external paternal
doses had been reliably monitored, which
could, however, well have been correlated
with internal doses received by the workers
at the Sellafield plant.
The possible association of internal
exposures with somatic effects among nuc-
learworkers has also been noted in some of
the studies discussed previously, though
estimates of internal doses have not been




Prenatal X-ray examinations. The Oxford
Survey of Childhood Cancers (OSCC)
includes data on all British children who
died from cancer before the age of16 years,
starting in 1953. Its most recent findings
were based on more than 15,000 geograph-
ically and birth-date matched case-control
pairs. In the period 1950- 1979, about 7%
of all childhood cancer deaths and 8% of
those with onset ofmalignancy between the
ages of 4 and 7 years were associated with
prenatal obstetric X-ray examinations, with
an estimated average dose ofabout 0.5 cGy
in the 1950s. The dose per examination
declined significantly over subsequent
years. The resulting excess risk from prena-
tal X-ray examinations ofthe fetus was esti-
mated to be about 20 deaths per 104 per-
son-cGy, with a three times higher risk for
exposure during the first trimester ofpreg-
nancy than during the last trimester
(82-86). This fetal risk factor during the
first trimester is about nine times that given
by BEIR V for a general population (2).
Also, there remains an unexplained discrep-
ancy between in utero radiogenic cancer
risks for a normal population ofchildren in
Great Britain and for prenatally exposed
children ofA-bomb survivors who werestill
alive in 1950 (87). On that basis, the
OSCC team's claim of a causal relation
between fetal exposures and induction of
excess childhood cancers was rejected for
decades. Meanwhile, Stewart and Kneale
(25,26) presented evidence from the LSS
data that could explain the lack ofconcor-
dance on account ofsignificant differences
between populations and their post-expo-
sure experiences. A U.S. tri-state leukemia
survey found parental preconception and
prenatal exposures ofchildren to diagnostic
X-rays to be associated with increased risks
for leukemia and a number of other dis-
eases in children (88).
Childhoodmortalities andexternalback-
ground radiation. In the past, a number of
studies claimed lower cancer mortality
rates in geographic locations with higher
background exposures. Such findings have
been cited to claim beneficial effects of
low-dose radiation (hormesis) (89).
However, when a number ofsuch studies,
based on U.S. vital statistics data, were
critically analyzed, the authors concluded:
"When we adjust linearly for altitude, the
negative correlations between mortality
and background radiation all disappear or
become positive. . . . We see no support
here for the claim that ionizing radiation is
beneficial at low doses" (90: 388).
Nevertheless, a second international con-
ference on hormesis, held in Kyoto, Japan,
inJuly 1992, attracted about 250 scientists
from all over theworld.
With fetal tissue being particularly sen-
sitive to radiation during its earliest period
of development (85), local variations in
neonatal mortality may be expected to be
correlated positively with local variations of
external exposures (or with internal deposi-
tion ofradioactive contaminants).
A Birmingham team of scientists was
able to correlate the very large database on
the geographical distribution ofchildhood
cancers in Great Britain ofthe OSCC with
accurate measurements of terrestrial y-ray
dose rates over a 100 km xlOO km grid
covering England, Scotland, and Wales
(91). The terrestrial doses for that areavary
by up to a factor offive, between about 15
nGy/hr and 80 nGy/hr (0.013-0.070 cGy
annually). This study suggests that "back-
ground radiation might be an element of
the causal chain of the majority of child-
hood cancers" (91: 16). It is noteworthy
that a simple regression analysis of child-
hood cancers found a negative correlation
with dose, in qualitative agreement with
the above-mentioned studies with inade-
quate controls for confounding factors that
continue to be cited in support ofradiation
hormesis. When confounding socioeco-
nomic factors, identified as being strongly
correlated with childhood cancer mortali-
ty, were included in the OSCC analysis,
the association with background dose
turnedsignificantlypositive.
Consistent with the British OSCC
results, a recent U.S. study also found a sig-
nificant association between childhood can-
cer incidence and a variation in annual
external background -raydose rate by near-
ly a factor two (0.05-0.092 cGy per year)
over an areawithin a radius ofapproximate-
ly 10 miles from the Three Mile Island
nuclear plant. On the basis of risk factors
derived from theA-bomb survivorstudy, no
detectable trend in cancer among children
should have been found from variations in
background exposures ofsuch small magni-
tude. This study, however, found a 50%
increase in risk ofcancer for children under
15 years with every 0.01 cGy increase in
estimated annual background 7-ray dose
(92). As in the British background study
above, the high sensitivity to radiation is
most likely related to exposures during the
earliest fetal stages ofdevelopment.
Increased cancer risk after scalp irradia-
tion byX-rays. Modan et al. (93) found an
increased risk ofcancer for the most recent
5-year period of a long-term follow-up
study ofIsraeli children who had scalp irra-
diation for tinea capitis between 1949 and
1959. The original cohort included 10,834
irradiated children. Estimated mean doses
were 9 cGy to the thyroid, 4.8-6.6 cGy to
the pituitary, and 1.6 cGy to the breast.
Until 1982 there were no indications ofan
increased cancer risk compared to matched
controls. Since then, however, incidence of
breast cancer increased significantly, show-
ing a long latency period for induction in
childhood. A high relative risk ofabout 12
(with a large uncertainty) was found in
women who had been exposed to a mean
breast dose of 1.6 cGy at age 5-9 years.
Thyroid cancers eventually became also
more frequent in the exposed population.
Environmental Contamination from
Radioactive Fallout
In contrast to the extensive epidemiologi-
cal literature pertaining to solid cancer and
leukemia induction from well-defined and
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monitored external low-dose exposures, far
fewer studies have been published on
reported health effects among populations
most likely affected by long-term low-dose
irradiation from a variety of inhaled or
ingested radioisotopes, originating from
radioactive fallout. In part, this may be a
reflection of the difficulties in evaluating
low and persistent internal doses. Various
biomarkers are currently under investiga-
tion for possible future use as retroactive
biological dosimeters for internally exposed
persons. More importantly, however, stan-
dard epidemiological methods are ill suited
to establish plausible association between
multiple radioisotope exposures and a
broad spectrum of poorly defined disease
patterns that have traditionally not been
accepted as possible consequences of low-
dose exposures by radiation experts.
Leukemia mortality and thyroid disease
downwindfrom the Nevada test site. Near
the nuclear test sites in Nevada, a
case-control study was conducted involv-
ing 1177 individuals (cases) who died of
leukemia between 1952 and 1981 and
5,330 persons who died of other causes
(controls). The authors estimated active
bone marrow dose from external exposure
to radioactive deposition on the soil from
fallout to range from 0 to 3.0 cGy. The
median bone marrow dose for all cases and
controls was 0.32 cGy, compared to a dose
of 0.49 cGy from terrestrial and cosmic
background radiation accumulated over
the period offallout (7 years). Asignificant
association with external marrow dose was
found for acute leukemias discovered from
1952 to 1963 among those individuals
who were younger than 20 years at expo-
sure. The observed risks at these low expo-
sures are about double those predicted by
the BEIR V (2) model, but the difference
was not statistically significant. The results
are, however, consistent with several previ-
ous studies ofpopulations exposed to fall-
out from the Nevada atmospheric bomb
tests (94). While a positive association was
observed between leukemia and external
exposure, internal exposures from ingested
fission products might well play a domi-
nant role if tissue concentrations of
radioisotopes can be assumed to be corre-
latedwith levels ofexternal contamination.
Also, a statistically significant excess of
thyroid neoplasms was found among
schoolchildren from communities in
southwest Utah, southeast Nevada, and
southeast Arizona, potentially exposed to
fallout between 1951 and 1958. Estimated
doses from radioactive iodine isotopes to
the thyroid ranged from 0 to 460 cGy (17
cGy average for Utah )(95).
Leukemia clusters near civilian nuclear
powerplants. An increased incidence of
leukemia was found by Clapp et al. (96)
during the years 1982-1985 in a five-town
area of Massachusetts near Plymouth,
where the Pilgrim I nuclear plant is known
to have released various radioisotopes dur-
ing the years 1974-1975. Age-adjusted
morbidity odds ratios of about 1.4 were
calculated, comparing incidence for the 4-
year period, 1982-1985, in five coastal
towns near the plant with that in the sur-
rounding communities in southeast
Massachusetts. The excess was primarily
found in adults and the elderly. The
authors claim the most likely association to
be with airborne radioactive effluents
trapped in a coastal flowpattern.
In contrast, a study by Jablon et al.
(97), sponsored by the U.S. National
Cancer Institute, found no statistically sig-
nificant excess risk of death from any of
the cancers the authors surveyed for people
living near nuclear facilities. The study
involved 107 U.S. counties with or near
nuclear installations. The authors state that
any excess cancer risk present in those
counties was too small to be detected with
the statistical methods employed in the
study. In a critical review, Clapp (98) sug-
gests that the seemingly discrepant results
of the two studies might be due to their
different sensitivities for detecting small
excess risks. Leukemia clusters have also
been reported recently around several
German nuclear powerplants (99,100).
Leukemia in the United States andfall-
outfrom nuclear testing. Levels of deposi-
tions oflow levels offission products such
as strontium-90 from atmospheric nuclear
explosions have been found to be associat-
ed with increased leukemia rates among
children. The strongest association of a
composite exposure index that used stron-
tium-90 concentrations in food, cow's
milk, and human bone was found with
acute and myeloid leukemia rates about
5.5 years after the peaks in fallout among
5-9 year olds. Regional differences in
leukemia rates corresponded to different
levels ofthe exposure index. The leukemia
rates fell again sharply after the cessation of
atmospheric tests (101).
Radioactive emissions and breast cancer.
Breast cancer mortality rates for the years
1984-1988 were found to be associated
with documented cumulative airborne
releases of fission products (including
iodine-131, strontium-90, strontium-89,
and cesium-137) from nuclear power
plants in nine census regions ofthe United
States during the period 1970-1987.
Assuming the average inhaled or ingested
radioactivity (i.e., internal dose) to be
directly correlated with these releases, the
authors found approximately a logarithmic
relationship between mortality and expo-
sure (102). Such a supra-linear dose-
response relationship for internal exposure
in a dose range, estimated to be of the
order of external yearly background (if
confirmed), would be qualitatively consis-
tent with a proposed disease mechanism
that involves biochemical chain reactions
in human tissue, progressing from oxygen
free-radicals produced at low dose rates of
ionizing radiation and subject to saturation
concentrations (14,103).
In light of the special sensitivity of the
developing fetus and breast tissue to radia-
tion, a direct link between ingestion of
radioisotopes by the pregnant mother and
subsequent birth outcomes or induction of
breast cancer provides a plausible explana-
tion for the above observations, provided
that other time-correlated confounding
factors can be reasonably excluded.
Radioactivefalloutandcongenitaldefects.
1) A discontinuity in historical trends for
early infant (neonatal) mortality in West
Germany before April 1986 and after fall-
out from the Chernobyl reactor accident
had reached western Europe showed a sig-
nificant association with higher levels of
fall-out in southern as compared to north-
ern Germany (104-106). The authors' pro-
posed causal association ofinfant mortality
with environmental radioactive contamina-
tion involving the food chain has been sig-
nificantly strengthened by another, com-
pletelyindependent study.
2) First-day infant mortality, first-
through sixth-day infant mortality, and
stillbirth statistics have been followed for
England and Wales and for the United
States from 1935 to 1987. Approximately
exponentially declining historical trends
were interrupted in the early 1950s for
about 10 years but were then followed by a
steeper decline until the rates resumed
their pre-1950s exponentially declining
trend in the late 1970s. An earlier hypoth-
esis had linked the interruption in declin-
ing mortality rates to changes in neonatal
care for sick newborn infants, including
restrictions in oxygen intake. Whyte's
(107) analysis of the relevant statistical
data and their correlation with time peri-
ods during which such changes in neonatal
care can be documented in England,
Wales, and the United States makes the
oxygen restriction hypothesis untenable or
incomplete. Whyte concludes that his
observations indicate a common mater-
nal-fetal cause such as an economic or
environmental factor (107). As the period
from 1950 to 1980 extends from postwar
economic depression into recovery, wealth,
and recession, there are no clear economic
or universal nutritional correlates, although
an analysis in greater detail would be valu-
able. Among environmental factors, the
documented rise in strontium-90 deposi-
tions from fallout following atmospheric
nuclear testing between 1950 and 1964
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stands out, suggesting that it is a likely cor-
relate with the observed changes in trends.
3) A recent study by a team ofscientists
from the official childhood cancer registry
in Mainz, Germany, reported a statistically
significant increase in a very rare kind of
tumor ofthe nerve cells in young children
neuroblastomaa) for babies born in 1988, 2
years after the explosion of the Chernobyl
reactor (108). For the 1988 birth cohort
in areas with more than 104 Bq/m
cesium-137 soil contamination, the num-
ber of cases recorded until mid-1992 was
1.96 times the expected number for
Germany during the years 1980-1987
(22.5 cases ger 106 live births); for areas
with 6 x 10 -10 Bq/m contamination,
the number ofcases was 1.65 the expected
number, and for areas with less than 6 x
103 Bq/m2 radioactive cesium deposition
the ratio was 0.98. Similar increases in
neuroblastoma rates were found for babies
born for the years after 1988. Given the
clear association of relative risk for a rare
congenital defect with levels of radioactive
cesium contamination, a causal relation-
ship is likely.
4) Based on changes in historical
trends, Gould and Sternglass (109) suggest
an association between a rise in the per-
centage of low-birthweight live births in
the United States from 1945 to 1965 and
the observed buildup of strontium-90 in
human bone following the period of
atmospheric bomb tests.
Health effects around ChernobyL Much
publicity was given to the negative findings
ofan epidemiological study by a large inter-
national team ofprestigious radiation scien-
tists sponsored by the International Atomic
Energy Agency in Vienna (IAEA) and the
World Health Organization (WHO). The
purpose of the study was to verify the
reported appearance ofa broad spectrum of
medical problems among the surrounding
populations affected by radioactivity
released in the Chernobyl explosion. The
study found no significant association
between radioactive contamination of the
environment and the repor-ted diseases.
While confirming an increased rate for a
variety ofhealth problems, the team ofradi-
ation experts suggested fear of radiation
(radiophobia) as the most likely cause ofthe
medical symptoms (110). The international
team had relied on questionable health
records supplied by the government of the
former Soviet Union, rather than on hospi-
tal records, the study population did not
include the thousands of "reactor liquida-
tors," and the controls were chosen from
areas of the same general district that had
been onlyslightlyless contaminated.
The IEAE experts' conclusion stands in
marked contrast to clinical reports from
Minsk (Belarus) of an alarmingly large and
persisting increase of particularly invasive
thyroid cancers in children shortly after the
Chernobyl accident (111). A companion
publication by five western scientists,
including a member ofWHO, validated the
Belarus data (112) and highlighted the dis-
parity between these and the earlier IAEA
findings. The reports from Minsk, together
with other clinical reports on the cata-
strophic health consequences of the
Chernobyl explosion in other parts of the
former Soviet Union and in Poland (113-
115) and the questionable database, as well
as their choice of controls, discredit the
IAEA scientists' conclusions. Yet, these
authoritative conclusions have never been
revised. Given a unique opportunity to
research the multiple effects ofwidespread
radioactive contamination on public health,
reliable epidemiological studies with partici-
pation ofindependent scientists, not under
government agencies' contracts, should
receive highest priority for funding.
Chromosome aberrations induced by
Chernobylfallout. Cytogenetic analyses,
performed on peripheral blood lym-
phocites from members ofthe populations
affected by fallout from the Chernobyl
explosion, yielded a spectrum of chromo-
some aberrations. Scheid et al. (116) and
Verschaeve et al. (117) found significant
increases in chromosome aberrations about
5 years after the accident, which they relat-
ed to continued exposures from incorpo-
rated radioisotopes. Reliable dose estimates
for these individuals were not available. On
the other hand, an IAEA-sponsored study
(110) (the same study that related a broad
spectrum of diseases among that popula-
tion to radiophobia) found no significantly
elevated levels of such aberrations in the
blood of similarly exposed populations.
This finding was supported by Neel et al.
(118). However, the latter team used for
their controls a population with a 10 times
higher background level of aberrations
than that usually quoted in the relevant lit-
erature. These authors postulate that the
appearance of "rogue" lymphocytes (cells
with multiple aberrations) has a viral ori-
gin, while the findings by Scheid et al.
(116) and by Verschaeve et al. (117) make
a plausible case for their association with
internally embedded plutonium particles
(a-emitters). Biological dosimetry, useful
in retrospective studies, is currently being
developed, but it involves still very costly
techniques (116,119-122).
Conclusions and Discussion
A number offindings reviewed in the pre-
vious sections are at variance with the sum-
maries of the "state of knowledge," which
have been primarily based on official inter-
pretations of the A-bomb survivor follow-
up study. Neither the fetal hypersensitivity
to radiation, nor an increase in susceptibili-
ty for cancer induction for an aging popu-
lation are part of the accepted notions on
radiation effects at low doses. Nor does this
body of assumptions link low-dose expo-
sures resulting from radioactive fallout
(either from nuclear testing or from reactor
accidents) to any of the observed congeni-
tal effects reported. When levels of fallout
contamination over large areas ofthe globe
became known, local authorities every-
where, referring to the pronouncements by
official national and international radiation
regulatory commissions, reassured the pop-
ulations under their jurisdiction that their
levels ofexposure would be much too low
to cause any adverse health effects. In the
light ofthe foregoing evidence, sadly, these
statements have now lost their credibility.
Also, on the basis of the foregoing sum-
maries of studies, we draw the following
conclusions below.
Dose-effect relation at very low doses.
While the A-bomb survivor mortality data
from 1950 to 1985 yield a nonthreshold
linear dose-effect relation for cancers (other
than leukemia) down to about 20 cGywith
a suggestion of an increased excess relative
risk in the lowest dose range, the most
recently published cancer incidence statis-
tics (1950-1987) (36) show a statistically
strong nonthreshold linear acute dose-
effect relation for all solid tumors down to
the 1-10 cSv organ dose range, with an
excess relative risk about 40% larger than
that derived from the mortality data. Some
ofthe epidemiological studies ofprotracted
occupational exposures with lifetime accu-
mulated doses under 50 cSv and mean
doses of the order of natural background
find excess risks per unit dose for cancers
substantially in excess ofthose predicted by
linear extrapolation from the LSS mortality
or the incidence data. This apparent dis-
crepancy in initial slope of the dose-effect
curve could be due to bias from selection
effects (25,26), uncertainties in dose assign-
ments in the LSS cohort, or the accumulat-
ed occupational doses (55,56). However,
we like to emphasize that the hypothesis of
a universal dose-effect relation, which
would require consistency ofrisk over such
widely different population characteristics
and conditions of radiation exposures,
remains unproven.
Presumed reduced biological effectiveness
ofionizing radiation. The occupational
exposure studies reviewed here, the prena-
tal X- ray and external background expo-
sure studies, as well as the studies related to
airborne radioactive emissions, are all
inconsistent with the hypothesis ofreduced
biological effectiveness of ionizing radia-
tion at protracted irradiation.
Enhanced biologicaleffectiveness ofmed-
ical X-rays relative to high-energy y-rays.
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This extremely important question in
terms of its implications for public health
has only been touched upon in the BEIR
V report by referring to a 1986 review by
the International Commission on Rad-
iation Units and Measurement (5), but
without in-depth discussion. BEIR V (2)
suggests, however, that the radiation risk
estimates as derived from the acute y-ray
exposures of the Japanese survivors, which
form the basis for all radiation protection
guidelines, may underestimate these risks
by a factor of two for medical, industrial,
or other low-energy X-ray exposures. In
the three reviews of the current state of
knowledge of radiation effects, especially
directed toward physicians, this topic is
not even listed among the open questions,
implying that the generally accepted risk
values (derived from the A-bomb studies)
are applicable to all medical exposures as
well. Yet, there are well-documented find-
ings (123,124) of twice as large a muta-
tional effect in Tradescantia for 250-kVp
X-rays compared to cesium-137 y-rays, and
there is a physical basis for expecting such
a difference in biological effectiveness. The
significance of these radio-biological find-
ings for human exposures is an unsettled
question with broad ramifications for radi-
ation protection.
Free radicals, low-dose exposures and
health. Except for mentioning the possible
creation of free radicals by ionizing radia-
tion in the BEIR V report and by one of
the reviews cited, the possibility that this
interaction and disturbance ofintracellular
communication could provide a strongly
nonlinear alternative biological mechanism
to the well-known direct mutational inter-
actions ofradiation with human cell nuclei
in the induction of disease-in particular,
at very low doses-has not become part of
the discussions of low-dose radiation
effects, in spite of a burgeoning literature
linking free-radicals to a wide spectrum of
diseases, as well as suggesting possible
treatments (7,103,121).
Radiation hormesis hypothesis. All ofthe
low-dose studies of radiation effects in
human populations reviewed above are
inconsistent with hypothesized long-term
cancer-reducing effects of such exposures
in excess of unavoidable natural back-
ground of human populations (hormesis).
One can only speculate about the contin-
ued popularity of this conjecture among
some groups ofradiation experts.
Suggestions for New Research
By comparing statements about the above-
listed five aspects in different authoritative
presentations of known health effects of
low-dose exposures and by focusing on
inconsistencies or selective omissions, we
have identified unsettled questions in the
mainstream state of knowledge. However,
the identification ofunsettled questions can
be extended by reviewing findings from a
number of unrefuted studies on popula-
tions other than the LSS cohort ofA-bomb
survivors that are inconsistent with tradi-
tional notions and, therefore, have been
rejected, ignored, or glossed over in pur-
portedly comprehensive reviews of the
field. These inconsistencies raise a range of
additional questions about the limitations
ofcurrently accepted concepts.
Finally, in the aftermath of the wide-
spread fallout from the explosion of the
Chernobyl reactor in the former Soviet
Union, there are suspected associations of
disease with radiation exposures that have
barely been reported in the scientific litera-
ture. An additional relevant summary of
observed health effects as a consequence of
the Chernobyl nuclear explosion, presented
at the International Workshop on the
Impact of the Environment on Repro-
ductive Health (30 September-4 October
1991, Copenhagen, Denmark) was brought
to our attention at the time this paper was
submitted (125). In the United States, only
a handful of government-funded health
studies have been initiated among popula-
tions ("downwinders") that have been at
risk for internal exposures by various path-
ways as a result of radioactive releases into
the environment from weapons production
and testing facilities, in some instances pos-
sibly in synergism with chemical exposures.
A few examples have been presented. These
populations at risk include large groups of
civilians and tens of thousands of military
personnel who had been stationed at
nuclear sites or who were involved with
nuclear bomb tests. Some official epidemio-
logical studies on these populations were
admittedly "defensive" in nature (126),
responding to pressures by affected popula-
tions for material compensation. On the
other hand, an increasing number ofwell-
researched investigative reports and small-
scale health surveys, organized by members
of the affected populations themselves
(127-132) document the existence of clus-
ters ofcancers and similar patterns ofother
serious health problems among down-
winders near various nuclear sites. An
increasing body of verifiable observations,
not matched by reasonable alternative
explanations, presents a challenge to public
health agencies to commence large-scale,
unified health surveys and to radiation
experts to extend their research strategies
into insufficiently investigated interactions
ofradiation with human health. There is an
urgent need for the formulation of novel,
guiding questions that need to be translated
into testable hypotheses.
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